Biobanking For Medicine Market Size, Share, Trends, Growth Outlook

The Global Biobanking for Medicine Market Size is estimated to register 10.6% growth over the forecast period from 2023 to 2030.

 

The market growth is driven by an increasing collaboration among biobanks, research institutions, and healthcare organizations on a global scale has become a prominent trend. Establishing biorepository networks facilitates the sharing of resources, standardization of procedures, and access to a more diverse range of biological samples. This collaborative approach accelerates research efforts and promotes the development of standardized protocols for sample collection and storage. Leading Companies focusing on Integration with Digital Health and Electronic Health Records (EHRs), Expansion of Biobanking into Rare Diseases and Population Genomics, Growing Emphasis on Ethical and Regulatory Compliance, and others to boost market shares in the industry.

 

Market Overview

The Biobanking for Medicine Market is experiencing robust growth, driven by the demand for high-quality biological samples for precision medicine, disease research, and drug development. Key components include sample collection and storage, efficient data management, and adherence to ethical and regulatory frameworks. Technological advancements, global collaborations, and applications in genomics and translational medicine contribute to the market's expansion. Challenges involve ethical considerations, standardization, and infrastructure requirements. Future trends include integration with digital health, advancements in AI for data analysis, and potential expansion into rare diseases and population genomics, reflecting the dynamic nature of the field.

 

Market Dynamics

Market Trends- Biobanks are filling the critical gaps in research data, propelling breakthroughs in personalized medicine.

Biobanking significantly contributes to advancing research and fostering breakthroughs in personalized medicine by addressing crucial gaps in research data. These repositories house diverse biological samples like tissues, blood, and DNA, along with pertinent clinical and demographic information, serving as a valuable resource to comprehend the genetic foundations of diseases. Researchers exploring the well-curated collections gain insights into individual variations essential for tailoring medical treatments to specific patient profiles. The integration of biobanking data with state-of-the-art technologies, including artificial intelligence and big data analytics, amplifies the exploration of intricate genetic patterns and biomarkers. This collaborative synergy propels the evolution of personalized medicine, enabling more accurate diagnostics, targeted therapies, and ultimately, improved patient outcomes. Globally, the concerted efforts of biobanks, research institutions, and healthcare organizations mark a transformative era in comprehensive health research and delivery.

 

Market Driver- As the population ages, the prevalence of chronic diseases is skyrocketing, posing a major challenge for healthcare systems worldwide.

The aging of the global population has led to a notable increase in the prevalence of chronic diseases, presenting a significant challenge for healthcare systems worldwide. The aging demographic is becoming more susceptible to conditions like cardiovascular diseases, diabetes, and neurodegenerative disorders, emphasizing the need for a proactive and personalized healthcare approach. Biobanking for Medicine assumes a pivotal role in tackling this challenge by providing a platform for collecting and storing biological samples essential for researching and comprehending the underlying mechanisms of these chronic conditions. The presence of well-curated samples in biobanks empowers scientists and researchers to explore the genetic and molecular aspects of age-related diseases, paving the way for targeted therapies and innovative interventions. The intersection of biobanking and the escalating prevalence of chronic diseases highlights the pressing need to advance medical research for effective management and mitigation of these conditions on a global scale.

 

Market Opportunity- The fusion of biobanking and big data analytics fuels groundbreaking discoveries in medicine, paving the way for personalized treatments.

The integration of biobanking and big data analytics is propelling groundbreaking advancements in medicine, marking the dawn of a new era for personalized treatments. This collaboration leverages the extensive repositories of biological samples found in biobanks, including tissues, blood, and genetic materials, and integrates them with advanced data analytics tools. The outcome is an unparalleled capability to analyze intricate patterns, identify biomarkers, and gain profound insights into individual variations. This transformative approach not only deepens our comprehension of diseases but also drives the development of precise and customized medical interventions. The fusion of biobanking and big data analytics signifies a fundamental shift, providing researchers and clinicians with potent tools to unlock the full potential of personalized medicine, significantly influencing the course of healthcare advancements.

 

Market Share Analysis- Personalized Medicine Biobanking for Medicine Market will register the fastest growth

The Global Biobanking for Medicine Market is analyzed across Drug Discovery, Genomic Research, Personalized Medicine, Regenerative Medicine, and others. Personalized Medicine is poised to register the fastest growth. The Biobanking for Medicine Market is closely linked with the evolution of personalized medicine, where biobanks, as repositories of diverse biological samples, play a crucial role. Supporting the principles of personalized medicine, biobanks enable genetic insights, biomarker discovery, and prediction of treatment responses by providing researchers access to a varied pool of samples. This facilitates the development of targeted therapies based on individual genetic makeup, contributing to disease prevention and early detection. Biobanks also aid clinical trials and drug development by ensuring diverse and well-characterized samples. The integration of biobanking and personalized medicine exemplifies a collaborative approach to healthcare, emphasizing the customization of treatments based on genetic, clinical, and lifestyle data, with ongoing advancements expected to enhance precision in healthcare delivery.

 

Market Share Analysis- Tissues held a significant market share in 2023

The Global Biobanking for Medicine Market is analyzed across various sample types including Tissues, Blood, Cells, and others. Of these, Tissues held a significant market share in 2023. Tissue biobanking is a pivotal component of the Biobanking for Medicine Market, crucial for medical research and personalized medicine. These biobanks collect, process, and store diverse tissue samples, providing a comprehensive resource for exploring the genetic and molecular aspects of diseases. Tissue biobanking supports biomarker discovery, drug development, and targeted therapy research by offering a well-preserved collection of biological materials. With a growing demand for personalized treatments, tissue biobanking plays a key role in advancing precision medicine, and shaping the future of medical research and healthcare delivery.

 

Biobanking For Medicine Market Segmentation

By Application

• Drug Discovery
• Genomic Research
• Personalized Medicine
• Regenerative Medicine

 

By Sample Type

• Tissues
• Blood
• Cells
• Others

 

By End User

• Academic & Research Institutions
• Hospitals
• Pharmaceutical Companies
• Others

 

By Region    

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
•  Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Biobanking For Medicine Market Companies

• Thermo Fisher Scientific Inc (United States)
• Brooks Life Sciences (United States)
• Qiagen N.V (Netherlands)
• Hamilton Company (United States)
• Greiner Bio-One (Austria)
• Promega Corporation (United States)
• Becton, Dickinson and Company (BD) (United States)
• BioLife Solutions Inc (United States)
• Tecan Group Ltd (Switzerland)
• Charles River Laboratories (United States)
• BioStorage Technologies Inc (United States)
• Biocair (United Kingdom)
• TTP Labtech (United Kingdom)
• Beckman Coulter Inc (United States)
• StemExpress (United States)
• GenScript Biotech Corporation (China)

 

*List not exhaustive

 

Biobanking For Medicine Market Outlook 2023

1 Market Overview

1.1 Introduction to the Biobanking For Medicine Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Biobanking For Medicine Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Biobanking For Medicine Market Companies with Area Served

4.2.2 Products Offerings Global Biobanking For Medicine Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 Post-COVID-19 Scenario- Low Growth Case

5.1.3 Post-COVID-19 Scenario- Reference Growth Case

5.1.4 Post-COVID-19 Scenario- Low Growth Case

 

6 Global Biobanking For Medicine Market Trends

6.1 Global Biobanking For Medicine Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Biobanking For Medicine Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Biobanking For Medicine Revenue (USD Million) and CAGR (%) by Regions (2018-2030)

 

7 Global Biobanking For Medicine Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Biobanking For Medicine Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Biobanking For Medicine Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Biobanking For Medicine Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Biobanking For Medicine Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Biobanking For Medicine Development Regional Status and Outlook

8.1 Global Biobanking For Medicine Revenue (USD Million) By Regions (2018-2022)

8.2 North America Biobanking For Medicine Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Biobanking For Medicine Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Biobanking For Medicine Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Biobanking For Medicine Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Biobanking For Medicine Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Biobanking For Medicine Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Biobanking For Medicine Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Biobanking For Medicine Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Biobanking For Medicine Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Biobanking For Medicine Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Biobanking For Medicine Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Biobanking For Medicine Revenue (USD Million) by Applications (2018-2022)

8.5 South America Biobanking For Medicine Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Biobanking For Medicine Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Biobanking For Medicine Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Biobanking For Medicine Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Biobanking For Medicine Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Biobanking For Medicine Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Biobanking For Medicine Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Biobanking For Medicine Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Biobanking For Medicine Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Biobanking For Medicine Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Biobanking For Medicine Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Biobanking For Medicine Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Biobanking For Medicine Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Biobanking For Medicine Development Regional Status and Outlook Forecast

11.1 Global Biobanking For Medicine Revenue (USD Million) By Regions (2023-2030)

11.2 North America Biobanking For Medicine Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Biobanking For Medicine Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Biobanking For Medicine Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Biobanking For Medicine Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Biobanking For Medicine Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Biobanking For Medicine Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Biobanking For Medicine Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Biobanking For Medicine Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Biobanking For Medicine Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Biobanking For Medicine Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Biobanking For Medicine Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Biobanking For Medicine Revenue (USD Million), by Applications (2023-2030)

11.5 South America Biobanking For Medicine Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Biobanking For Medicine Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Biobanking For Medicine Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Biobanking For Medicine Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Biobanking For Medicine Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Biobanking For Medicine Revenue (USD Million), by Region (2023-2030)

11.6.2 Middle East and Africa Biobanking For Medicine Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Biobanking For Medicine Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Biobanking For Medicine Market Companies with Areas Served

Table 3 Products Offerings Global Biobanking For Medicine Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Biobanking For Medicine Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Biobanking For Medicine Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Biobanking For Medicine Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Table 11 Global Biobanking For Medicine Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Biobanking For Medicine Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Biobanking For Medicine Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Biobanking For Medicine Market Share (%) By Regions (2018-2022)

Table 16 North America Biobanking For Medicine Revenue (USD Million) By Country (2018-2022)

Table 17 North America Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Table 18 North America Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Biobanking For Medicine Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Biobanking For Medicine Revenue (USD Million) By Country (2018-2022)

Table 26 South America Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Table 27 South America Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Table 33 Global Biobanking For Medicine Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Biobanking For Medicine Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Biobanking For Medicine Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Biobanking For Medicine Revenue (USD)By Country (2023-2030)

Table 38 North America Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Table 39 North America Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Biobanking For Medicine Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Biobanking For Medicine Revenue (USD Million) By Country (2023-2030)

Table 47 South America Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Table 48 South America Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Biobanking For Medicine Revenue Market Share (%) By Type (2022)

Figure 5 Global Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Biobanking For Medicine Revenue Market Share (%) By Applications (2022)

Figure 7 Global Biobanking For Medicine Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Biobanking For Medicine Market Share (%) By Regions (2022)

Figure 9 North America Biobanking For Medicine Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Biobanking For Medicine Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Biobanking For Medicine Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Biobanking For Medicine Revenue Market Share (%) By Type (2030)

Figure 26 Global Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Biobanking For Medicine Revenue Market Share (%) By Applications (2030)

Figure 28 Global Biobanking For Medicine Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Biobanking For Medicine Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Biobanking For Medicine Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Biobanking For Medicine Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Biobanking For Medicine Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches For This Report

Figure 46 Data Triangulation

 

Biobanking For Medicine Market Segmentation

By Application

• Drug Discovery
• Genomic Research
• Personalized Medicine
• Regenerative Medicine

 

By Sample Type

• Tissues
• Blood
• Cells
• Others

 

By End User

• Academic & Research Institutions
• Hospitals
• Pharmaceutical Companies
• Others

 

By Region    

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
•  Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)